Employing multiple models, methods and mechanisms in bipolar disorder research.
@article{Williams2009EmployingMM,
title={Employing multiple models, methods and mechanisms in bipolar disorder research.},
author={Robin S. B. Williams},
journal={Biochemical Society transactions},
year={2009},
volume={37 Pt 5},
pages={
1077-9
}
}BD (bipolar disorder) is a devastating condition, giving rise to debilitating mood swings and a greatly increased likelihood of suicide. Research into the origins, progression and treatment of BD has been slow, primarily due to lack of suitable model systems for BD research. However, the complexity of the neurological basis for mood, variability in patient populations and the lack of clear readouts for BD diagnosis also provide significant problems for research in this area. In this Biochemical…
4 Citations
Brain arachidonic acid uptake and turnover: implications for signaling and bipolar disorder
- Biology, ChemistryCurrent opinion in clinical nutrition and metabolic care
- 2010
Evidence is summarized demonstrating that unesterified arachidonic acid in the plasma pool, which is supplied in part from adipose, is readily taken up and incorporated into brain phospholipids and could lead to new imaging techniques and the identification of novel therapeutic targets in excitotoxicity, neuroinflammation and bipolar disorder.
Aspirin, arachidonic acid and the regulation of mood.
- BiologyProstaglandins, leukotrienes, and essential fatty acids
- 2010
The antiepileptic drug valproic acid and other medium-chain fatty acids acutely reduce phosphoinositide levels independently of inositol in Dictyostelium
- BiologyDisease Models & Mechanisms
- 2012
The data show that VPA and a newly identified group of medium-chain fatty acids reduce phosphoinositide levels independently of inositol regulation, and suggest the reinvestigation of these compounds as treatments for epilepsy.
Investigating the effects of inositol depletion using a simple eukaryotic organism, Dictyostelium discoideum
- Biology, Chemistry
- 2016
Different cellular and metabolic effects for both inositol depletion and loss of Ino1 are identified, with implications for the understanding of human diseases.
References
SHOWING 1-10 OF 36 REFERENCES
Risk and resilience in bipolar disorder: rationale and design of the Vulnerability to Bipolar Disorders Study (VIBES).
- PsychologyBiochemical Society transactions
- 2009
The evidence for cognitive, brain structural and functional correlates of genetic predisposition to BD is reviewed and biological markers of risk as well as factors that might protect against disease expression are highlighted.
Neuropsychology of bipolar disorder: a review.
- Psychology, MedicineJournal of affective disorders
- 2002
A systematic review of the evidence of the burden of bipolar disorder in Europe
- Medicine, PsychologyClinical practice and epidemiology in mental health : CP & EMH
- 2009
Bipolar disorder is a major and underestimated health problem in Europe, and a number of issues impact on the economic burden of the disease, such as comorbidities, suicide, early death, unemployment or underemployment.
Disease Biomarkers in Cerebrospinal Fluid of Patients with First-Onset Psychosis
- Psychology, MedicinePLoS medicine
- 2006
The results suggest that the application of modern proteomics techniques, particularly mass spectrometric approaches, holds the potential to advance the understanding of the biochemical basis of psychiatric disorders and may in turn allow for the development of diagnostics and improved therapeutics.
Overview of patient care issues and treatment in bipolar spectrum and bipolar II disorder.
- Psychology, MedicineThe Journal of clinical psychiatry
- 2008
Broader definitions of bipolar spectrum disorders would allow clinicians to more accurately diagnose patients, rather than placing them in the catchall category of bipolar disorder not otherwise specified, and aid researchers in studying viable treatments options.
Neural network dysfunction in bipolar depression: clues from the efficacy of lamotrigine.
- Biology, PsychologyBiochemical Society transactions
- 2009
In healthy volunteers, lamotrigine had a facilitatory effect on the BOLD response to TMS (transcranial magnetic stimulation) of the prefrontal cortex, and in vitro, lamOTrigine enhanced the power of gamma frequency network oscillations induced by kainic acid in the rat hippocampus, an effect that was not observed with valproic acid.
Two peptidase activities decrease in treated bipolar disorder not schizophrenic patients.
- Medicine, PsychologyBipolar disorders
- 2004
The enzyme activity previously reported as plasma PO actually comprises two enzymes, PO and ZIP, which is restricted to blood plasma, whereas PO activity is present in the cytosol of lymphocytes, but can also be detected in blood plasma.
Genetics of bipolar disorder: successful start to a long journey.
- Psychology, BiologyTrends in genetics : TIG
- 2009
A common mechanism of action for three mood-stabilizing drugs
- Biology, PsychologyNature
- 2002
It is shown that all three lithium, carbamazepine and valproic acid drugs inhibit the collapse of sensory neuron growth cones and increase growth cone area, suggesting a molecular basis for both bipolar affective disorder and its treatment.
Targeting glycogen synthase kinase-3 in the CNS: implications for the development of new treatments for mood disorders.
- Biology, PsychologyCurrent drug targets
- 2006
The evidence described in this review suggests that regulating GSK-3 may represent a target for novel medications to treat mood disorders.